Loading...
CSL logo

CSL LimitedASX:CSL Stok Raporu

Piyasa Değeri AU$87.0b
Hisse Fiyatı
AU$180.50
Kullanılamıyor
1Y-33.1%
7D-0.5%
Portföy Değeri
​
Görünüm

CSL Limited

ASX:CSL Stok Raporu

Piyasa değeri: AU$87.0b

CSL (CSL) Hisse Özeti

CSL Limited, Avustralya, Amerika Birleşik Devletleri, Almanya, Birleşik Krallık, İsviçre, Çin, Hong Kong ve uluslararası alanda biyofarmasötik ürünlerin ve aşıların araştırılması, geliştirilmesi, üretimi, pazarlanması ve dağıtımı ile ilgilenmektedir. Daha fazla detay

Ödüller

Adil değer tahminimizden 38.9% daha düşük bir oranda işlem görüyor

Kazançların yılda 10.06% oranında artması öngörülüyor

Kazançlar son 5 yılda yılda 3.9% oranında arttı

Rakiplerine ve sektöre kıyasla iyi değerde işlem görüyor

Analistler hisse senedi fiyatının 28.1% oranında artacağı konusunda hemfikir

Risk Analizi

Risk kontrollerimizden CSL için herhangi bir risk tespit edilmedi.

CSL Community Fair Values

Create Narrative

See what 313 others think this stock is worth. Follow their fair value or set your own to get alerts.

CSL logo
CSL

CSL: Share Price Correction Will Present Opportunity As Vaccine Uncertainty Eases

Key Takeaways Operational transformation and investment in innovation are expected to drive margin expansion, earnings growth, and faster introduction of high-value therapies. Market expansion, a focused business structure, and strong demand for plasma and specialty products support sustainable top-line growth and premium positioning.
View narrative
AU$232.54
FV
22.4% değerinin altında içsel indirim
4.07%
Revenue growth p.a.
2.1k
users have viewed this narrative
2users have liked this narrative
0users have commented on this narrative
152users have followed this narrative
CSL logo
CSL

CSL will thrive with an 18% profit surge ahead

this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam
View narrative
AU$239.81
FV
24.7% değerinin altında içsel indirim
6.48%
Revenue growth p.a.
48
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
CSL logo
CSL

Margin Recovery And Operating Model Simplification Will Support A Stronger Long Term Outlook

Catalysts About CSL CSL is a global biopharmaceutical group focused on plasma derived therapies, vaccines and specialty medicines for rare and serious diseases. What are the underlying business or industry changes driving this perspective?
View narrative
AU$289.37
FV
37.6% değerinin altında içsel indirim
5.76%
Revenue growth p.a.
358
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
View Stock Community
UNCY logo
Unicycive Therapeutics

Looking to be second time lucky with a game-changing new product

Key Takeaways Unicycive has successfully completed clinical development of its lead asset, Oxylanthanum Carbonate (OLC). OLC has been designed to improve on current phosphate binders by offering better efficacy, fewer pills, and improved tolerability over alternative treatments for hyperphosphatemia chronic kidney disease patients on dialysis.Read more

View narrative
1.1k
users have viewed this narrative
4users have liked this narrative
0users have commented on this narrative
19users have followed this narrative
US$21.53
68.9% değerinin altında içsel indirim
stuart_roberts's Fair Value
Profit Margin
20%
Future PE
27x
Price in 2030
US$34.67

CSL Limited Rakipler

Fiyat Geçmişi ve Performans

Hisse fiyatlarındaki yükseliş, düşüş ve değişimlerin özeti CSL
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıAU$180.50
52 Haftanın En Yüksek SeviyesiAU$275.79
52 Haftanın En Düşük SeviyesiAU$168.00
Beta0.28
1 Aylık Değişim6.18%
3 Aylık Değişim0.82%
1 Yıllık Değişim-33.11%
3 Yıllık Değişim-40.81%
5 Yıllık Değişim-34.78%
Halka arzdan bu yana değişim22,462.73%

Son Haberler & Güncellemeler

Recent updates

CSL Limited's (ASX:CSL) Share Price Not Quite Adding Up

Sep 25
CSL Limited's (ASX:CSL) Share Price Not Quite Adding Up

Is CSL Limited (ASX:CSL) Trading At A 43% Discount?

Aug 07
Is CSL Limited (ASX:CSL) Trading At A 43% Discount?

Here's Why CSL (ASX:CSL) Can Manage Its Debt Responsibly

Jun 14
Here's Why CSL (ASX:CSL) Can Manage Its Debt Responsibly

Weekly Picks: 🧠 Alphabet’s AI edge, CSL’s pricing power, and a chip underdog

Apr 16
Weekly Picks: 🧠 Alphabet’s AI edge, CSL’s pricing power, and a chip underdog

CSL is undervalued in High Tax Scenario

CSL Behring: This is CSL's largest segment and the global leader (#1) in plasma therapies within an estimated US$30 billion industry.11 It focuses on researching, developing, manufacturing, and distri
User avatar

Advancements In iNOMi Technology And HEMGENIX Will Strengthen Market Position

Advancements in plasma collection and operational efficiencies are set to reduce costs and improve CSL Behring's margins, potentially boosting overall earnings.

Hissedar Getirileri

CSLAU BiotechsAU Pazar
7D-0.5%0.2%-1.0%
1Y-33.1%-34.3%3.9%

Getiri vs. Endüstri: CSL geçen yıl % -34.3 oranında getiri sağlayan Australian Biotechs sektörünü aştı.

Getiri vs Piyasa: CSL geçen yıl % 3.9 oranında getiri sağlayan Australian Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is CSL's price volatile compared to industry and market?
CSL volatility
CSL Average Weekly Movement2.7%
Biotechs Industry Average Movement11.2%
Market Average Movement9.4%
10% most volatile stocks in AU Market17.7%
10% least volatile stocks in AU Market3.4%

İstikrarlı Hisse Senedi Fiyatı: CSL son 3 ayda Australian piyasasına kıyasla önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: CSL 'nin haftalık oynaklığı ( 3% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
191629,904Paul McKenziewww.csl.com

CSL Limited, Avustralya, Amerika Birleşik Devletleri, Almanya, Birleşik Krallık, İsviçre, Çin, Hong Kong ve uluslararası alanda biyofarmasötik ürünlerin ve aşıların araştırılması, geliştirilmesi, üretimi, pazarlanması ve dağıtımı ile ilgilenmektedir. Şirket, CSL Behring, CSL Seqirus ve CSL Vifor segmentleri aracılığıyla faaliyet göstermektedir. CSL Behring segmenti plazma ürünleri, gen terapileri ve rekombinantlar üretmekte, pazarlamakta ve dağıtmaktadır.

CSL Limited Temel Bilgiler Özeti

CSL'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
CSL temel i̇stati̇sti̇kler
Piyasa değeriAU$87.01b
Kazançlar(TTM)AU$4.30b
Gelir(TTM)AU$22.27b
20.2x
F/K Oranı
3.9x
P/S Oranı

CSL aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
CSL gelir tablosu (TTM)
GelirUS$15.56b
Gelir MaliyetiUS$7.48b
Brüt KârUS$8.08b
Diğer GiderlerUS$5.08b
KazançlarUS$3.00b

Son Raporlanan Kazançlar

Jun 30, 2025

Sonraki Kazanç Tarihi

Feb 10, 2026

Hisse başına kazanç (EPS)6.23
Brüt Marj51.93%
Net Kâr Marjı19.30%
Borç/Özkaynak Oranı45.9%

CSL uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

2.3%
Mevcut Temettü Verimi
47%
Ödeme Oranı

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/02/06 18:21
Gün Sonu Hisse Fiyatı2026/02/06 00:00
Kazançlar2025/06/30
Yıllık Kazançlar2025/06/30

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

CSL Limited 25 Bu analistlerden 16, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Saul HadassinBarrenjoey Markets Pty Limited
Thomas WakimBell Potter
Lyanne HarrisonBofA Global Research